📊 ECIA Key Takeaways
Is Encision Inc. (ECIA) a Good Investment?
Encision Inc faces severe operational challenges with negative operating margins (-8.9%), negative net margins (-9.9%), and deteriorating profitability despite maintaining a healthy gross margin of 50.3%. The company is burning cash with negative operating cash flow (-$242.1K) and negative free cash flow (-$285.4K), while cash reserves are critically low at $71.7K, creating substantial solvency risk. Revenue contraction (-0.5% YoY) combined with inability to achieve profitability indicates fundamental business model stress.
Encision shows weak fundamental momentum: revenue is essentially flat while profitability has turned negative, with operating, net, and free cash flow margins all below zero. The balance sheet is not heavily levered, but the very low cash balance and continued cash burn reduce financial flexibility and raise execution risk for a company of this size. Until it demonstrates sustained margin recovery and positive operating cash flow, the fundamentals remain unattractive.
Why Buy Encision Inc. Stock? ECIA Key Strengths
- Solid gross margin of 50.3% indicates reasonable pricing power and cost of goods control
- Healthy current ratio of 2.28x suggests adequate short-term liquidity for immediate obligations
- Low leverage with debt-to-equity ratio of 0.08x provides minimal default risk from debt obligations
- Gross margin remains relatively solid at 50.3%, indicating the core product economics still have value
- Leverage is low, with debt/equity of 0.08x and limited long-term debt
- Current ratio of 2.28x suggests near-term obligations are manageable on paper
ECIA Stock Risks: Encision Inc. Investment Risks
- Critical cash burn with negative operating cash flow and dangerously low cash balance ($71.7K) creates imminent liquidity crisis
- Persistent unprofitability with negative operating income (-$278.3K) and negative net income (-$309.0K) indicates operational dysfunction
- Revenue stagnation (-0.5% YoY) combined with inability to control operating expenses suggests deteriorating competitive position in medical device sector
- Negative interest coverage ratio (-4.5x) indicates inability to service debt obligations from operations
- Zero insider buying activity in last 90 days suggests lack of management confidence in company prospects
- Net income and operating income are negative, with net loss worsening materially year over year
- Operating cash flow and free cash flow are negative, signaling weak earnings quality and internal funding pressure
- Cash balance is extremely thin at $71.73K, while quick ratio of 0.91x points to tighter real liquidity than the current ratio suggests
Key Metrics to Watch
- Operating cash flow trend - any further deterioration accelerates insolvency risk
- Cash balance depletion rate and runway to require financing or restructuring
- Revenue stabilization and operating expense reduction to achieve profitability inflection
- Gross margin sustainability as potential indicator of market competitiveness
- Operating cash flow and free cash flow trend
- Revenue growth paired with operating margin improvement
Encision Inc. (ECIA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.28x current ratio provides a solid financial cushion.
ECIA Profit Margin, ROE & Profitability Analysis
ECIA vs Healthcare Sector: How Encision Inc. Compares
How Encision Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Encision Inc. Stock Overvalued? ECIA Valuation Analysis 2026
Based on fundamental analysis, Encision Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Encision Inc. Balance Sheet: ECIA Debt, Cash & Liquidity
ECIA Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Encision Inc.'s revenue has declined by 14% over the 5-year period, indicating business contraction. The most recent EPS of $-0.06 indicates the company is currently unprofitable.
ECIA Revenue Growth, EPS Growth & YoY Performance
ECIA Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $1.5M | -$148.2K | $-0.01 |
| Q1 2026 | $1.6M | $22.0K | $0.00 |
| Q3 2025 | $1.6M | -$24.7K | $0.00 |
| Q2 2025 | $1.8M | -$7.5K | $0.00 |
| Q1 2025 | $1.6M | $22.0K | $0.00 |
| Q3 2024 | $1.6M | -$207.1K | $-0.02 |
| Q2 2024 | $1.7M | -$7.5K | $0.00 |
| Q1 2024 | $1.7M | -$140.5K | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Encision Inc. Dividends, Buybacks & Capital Allocation
ECIA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Encision Inc. (CIK: 0000930775)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ECIA
What is the AI rating for ECIA?
Encision Inc. (ECIA) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 84% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ECIA's key strengths?
Claude: Solid gross margin of 50.3% indicates reasonable pricing power and cost of goods control. Healthy current ratio of 2.28x suggests adequate short-term liquidity for immediate obligations. ChatGPT: Gross margin remains relatively solid at 50.3%, indicating the core product economics still have value. Leverage is low, with debt/equity of 0.08x and limited long-term debt.
What are the risks of investing in ECIA?
Claude: Critical cash burn with negative operating cash flow and dangerously low cash balance ($71.7K) creates imminent liquidity crisis. Persistent unprofitability with negative operating income (-$278.3K) and negative net income (-$309.0K) indicates operational dysfunction. ChatGPT: Net income and operating income are negative, with net loss worsening materially year over year. Operating cash flow and free cash flow are negative, signaling weak earnings quality and internal funding pressure.
What is ECIA's revenue and growth?
Encision Inc. reported revenue of $3.1M.
Does ECIA pay dividends?
Encision Inc. does not currently pay dividends.
Where can I find ECIA SEC filings?
Official SEC filings for Encision Inc. (CIK: 0000930775) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ECIA's EPS?
Encision Inc. has a diluted EPS of $-0.02.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ECIA a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Encision Inc. has a SELL rating with 84% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ECIA stock overvalued or undervalued?
Valuation metrics for ECIA: ROE of -16.6% (sector avg: 15%), net margin of -9.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ECIA stock in 2026?
Our dual AI analysis gives Encision Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ECIA's free cash flow?
Encision Inc.'s operating cash flow is $-242.1K, with capital expenditures of $43.2K. FCF margin is -9.1%.
How does ECIA compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -9.9% (avg: 12%), ROE -16.6% (avg: 15%), current ratio 2.28 (avg: 2).